BRCA1 and cancer: Missense mutation. Decreases transactivation compared to WT in mammalian cells (56). Reduces embryonic stem cell survival, upregulates microRNA-155 (upregulated in many human cancers, WT BRCA1 downregulates microRNA-155) (58).